Estrogen receptor β gene polymorphisms and susceptibility to uterine fibroids

References

• Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111:1037–1054.
   PubMed Web of Science ®Google Scholar
• Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol 2001;44:316–326.
   PubMed Web of Science ®Google Scholar
• Stewart EA. Uterine fibroids. Lancet 2001;357:293–298.
   PubMed Web of Science ®Google Scholar
• Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589–1592.
   PubMed Web of Science ®Google Scholar
• Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid 2005:2264–2282.
   PubMedGoogle Scholar
• Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004;10:207–220.
   PubMed Web of Science ®Google Scholar
• Bakas P, Liapis A, Vlahopoulos S, Giner M, Logotheti S, Creatsas G, Meligova AK, Alexis MN, Zoumpourlis V. Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 2008;90:1878–1885.
   PubMed Web of Science ®Google Scholar
• Benassayag C, Leroy MJ, Rigourd V, Robert B, Honore JC, Mignot TM, Vacher-Lavenu MC, Chapron C, Ferre F. Estrogen receptors (ERα/ERβ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol 1999;276:E1112–E1118.
   PubMed Web of Science ®Google Scholar
• Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995;80:1876–1881.
   PubMed Web of Science ®Google Scholar
• Kovacs KA, Oszter A, Gocze PM, Kornyei JL, Szabo I. Comparative analysis of cyclin D1 and oestrogen receptor (α and β) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod 2001;7:1085–1091.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Englund K, Masironi B, Eriksson H, Sahlin L. Different expression of estrogen receptors α and β in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment. Gynecol Endocrinol 2001;15:443–452.
   PubMed Web of Science ®Google Scholar
• Li S, McLachlan JA. Estrogen-associated genes in uterine leiomyoma. Ann NY Acad Sci 2001;948:112–120.
   PubMed Web of Science ®Google Scholar
• Strissel PL, Swiatek J, Oppelt P, Renner SP, Beckmann MW, Strick R. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid Biochem Mol Biol 2007;107:42–47.
   PubMed Web of Science ®Google Scholar
• Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O. Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res Treat 2008;110:507–520.
   PubMed Web of Science ®Google Scholar
• Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, Ortmann O. Estrogen receptor {β}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol 2007;193:421–433.
   PubMed Web of Science ®Google Scholar
• Alvarez-Millan JJ, Bocos C, Ferrin V, Lucas AR, Ruibal A, Schneider J. PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells. Oncology 2002;62:286–290.
   PubMed Web of Science ®Google Scholar
• Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 1999;84:350–353.
   PubMed Web of Science ®Google Scholar
• Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 2006;165:114–120.
   PubMedGoogle Scholar
• Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000;60:950–956.
   PubMed Web of Science ®Google Scholar
• Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA. Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 2003;278:20490–20499.
   PubMed Web of Science ®Google Scholar
• Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812–816.
   PubMed Web of Science ®Google Scholar
• Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Tamaki T, Mori I, Sakurai T, Kakudo K. Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancer. Anticancer Res 2002;22:1825–1828.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-α polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril 2006;86:686–693.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 2006;13:136–144.
   PubMedGoogle Scholar
• Gooden KM, Schroeder JC, North KE, Gammon MD, Hartmann KE, Taylor J, Baird DD. Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci 2007;14:117–120.
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Wang YK, Chang CC, Lin CS. Estrogen receptor α-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Human Reprod 2007;13:117–122.
   PubMed Web of Science ®Google Scholar
• Massart F, Becherini L, Gennari L, Facchini V, Genazzani AR, Brandi ML. Genotype distribution of estrogen receptor-α gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil Steril 2001;75:567–570.
   PubMed Web of Science ®Google Scholar
• Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, et al Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004;64:8891–8900.
   PubMed Web of Science ®Google Scholar
• Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002;83:149–155.
   PubMed Web of Science ®Google Scholar
• Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, Zillikens MC, Hofman A, van Leeuwen JP, Pols HA, et al Estrogen receptor α gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005;153:327–334.
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57–65.
   PubMed Web of Science ®Google Scholar
• Zofkova I, Zajickova K, Hill M. The estrogen receptor α gene determines serum androstenedione levels in postmenopausal women. Steroids 2002;67:815–819.
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Chang CC, Tsai FJ, Tsai HD, Yeh LS, Lin CC, Tsai CH. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 2003;79:96–99.
   PubMed Web of Science ®Google Scholar
• Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001;29:E88.
   PubMed Web of Science ®Google Scholar
• Iwamoto I, Fujino T, Douchi T, Nagata Y. Association of estrogen receptor α and β3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol 2003;102:506–511.
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Tziotis J, Evangelopoulos D, Fountas L, Vlachos G, Creatsas G, Sekeris CE, Moutsatsou P. Gene analysis of the N-terminal region of the estrogen receptor α in preeclampsia. Steroids 2001;66:695–700.
   PubMed Web of Science ®Google Scholar
• Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA, Girao MJ, Nishimura E, Baracat EC, Silva ID. Estrogen receptor α polymorphism and susceptibility to uterine leiomyoma. Steroids 2006;71:960–965.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Hosoi T, Shiraki M, Orimo H, Emi M, Muramatsu M, Ouchi Y, Inoue S. Association of estrogen receptor β gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000;269:537–541.
   PubMed Web of Science ®Google Scholar
• Rosenkranz K, Hinney A, Ziegler A, Hermann H, Fichter M, Mayer H, Siegfried W, Young JK, Remschmidt H, Hebebrand J. Systematic mutation screening of the estrogen receptor β gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 1998;83:4524–4527.
   PubMed Web of Science ®Google Scholar
• Sundarrajan C, Liao WX, Roy AC, Ng SC. Association between estrogen receptor-β gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001;86:135–139.
   PubMed Web of Science ®Google Scholar
• Gao J, Shan G, Sun B, Thompson PJ, Gao X. Association between polymorphism of tumour necrosis factor α- 308 gene promoter and asthma: a meta-analysis. Thorax 2006;61:466–471.
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Rabban JT, Chen LM, Dahiya R. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008;112:1964–1973.
   PubMed Web of Science ®Google Scholar
• Beleza-Meireles A, Kockum I, Lundberg F, Soderhall C, Nordenskjold A. Risk factors for hypospadias in the estrogen receptor 2 gene. J Clin Endocrinol Metab 2007;92:3712–3718.
   PubMed Web of Science ®Google Scholar
• Thellenberg-Karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-Balter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, et al Estrogen receptor β polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006;12:1936–1941.
   PubMed Web of Science ®Google Scholar